Please login to the form below

Not currently logged in
Email:
Password:

asthma

This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.

FDA approves new self-injection administration for Xolair

FDA approves new self-injection administration for Xolair

Drug is approved for asthma and other allergic and inflammatory conditions. ... This includes a number of allergic and inflammatory conditions, including moderate-to-severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.

Latest news

More from news
Approximately 65 fully matching, plus 491 partially matching documents found.

Latest Intelligence

  • Mapping at launch: it’s time to update the satnav Mapping at launch: it’s time to update the satnav

    COPD. It has recently been approved by the FDA for asthma too, but our analysis focuses on UK performance.

  • On our best behaviour On our best behaviour

    Historically, asthma patients were responsible for recording their own symptoms and exacerbations, which can be difficult to remember over long periods. ... The Propeller platform has been shown to increase medication adherence by up to 58%, increase

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    Working as a clinician at this time meant he was caring for patients with allergies and asthma, in particular severe asthma. ... Sputum provides a sample of the central airways which only makes up 10% of the airways, but asthma affects the whole of the

  • Could formulary intelligence be your brand differentiator?

    Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    The software helps differentiate patients from those suffering with similar symptoms that are actually a result of asthma and chronic obstructive pulmonary disease (COPD), and therefore diagnose CTEPH more reliably and

More from intelligence
Approximately 3 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Article

    Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma. ... Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies

  • Addressing Climate Impact: The Healthcare Paradox Addressing Climate Impact: The Healthcare Paradox

    Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.

  • How will the Tories’ historic win shape the NHS?

    conditions remotely, has huge potential for the NHS.  For example, with long term conditions such as asthma and diabetes, remote monitoring enables better self-management, which in turn, should lead to

  • Digital therapeutics and their impact on society

    This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma.

  • RWE Blog 1: Real-world challenges and real-world data

    In  a review of 870 out-patients with asthma and/or Chronic Obstructive Pulmonary Disease (COPD), only one in 20 asthma patients and one in six COPD patients met the typical

More from PMHub
Approximately 3 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics